je.st
news
Tag: for
PRESS RELEASE: Paul V. Profeta and Associates Completes Sale of 12 Walgreens-Occupied Properties to Inland Real Estate Acquisitions for $60 Million
2013-09-11 22:05:00| National Real Estate Investor
Kristin Kellum Paul V. Profeta and Associates,a leading real estate investment firm with assets across the country, today announced that the company has completed the sale of 12 properties in nine states to Inland Real Estate Acquisitions, Inc. read more
Discovery Of Massive Aquifers Could Be Game Changer For Kenya
2013-09-11 20:55:00| Climate Ark Climate Change & Global Warming Newsfeed
National Public Radio: Satellite imagery and seismic data have identified two huge underground aquifers in Kenya's drought-prone north, a discovery that could be "a game changer" for the country, NPR's Gregory Warner reports. The aquifers, located hundreds of feet underground in the Turkana region that borders Ethiopia and South Sudan, contain billions of gallons of water, according to UNESCO, which confirmed the existence of the subterranean lakes discovered with the help of a French company using technology originally...
Tags: for
game
discovery
massive
All Things Appy: Top 5 Free Map Apps for Firefox
2013-09-11 14:00:00| TechNewsWorld
This week, we look at the top five free map apps for the Firefox platform. These are power tools that will make it faster to look up addresses and gain new perspective on the locations you want to visit. We look at pop-up maps, unique map-related search add-ons and one alternative to common-old Google. First up? Quick Maps, which adds in-page Google Map frames to website street address listings.
Panasonic and Viessmann to sell Europes first fuel cell cogeneration system for homes
2013-09-11 13:30:53| Green Car Congress
Merck and AstraZeneca Enter License Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer
2013-09-11 09:15:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. & LONDON WHITEHOUSE STATION, N.J. & LONDON--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and AstraZeneca (NYSE: AZN) today announced a worldwide licensing agreement for Mercks oral small molecule inhibitor of WEE1 kinase (MK-1775). MK-1775 is currently being evaluated in Phase IIa clinical studies in combination with standard-of-care therapies for the treatment of patients with certain types of ovarian cancer. Language: English Contact: MerckMedia:Caroline Lappetito, (267) 305-7639orInvestor:Carol Ferguson, (908) 423-4465Justin Holko, (908) 423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
enter
agreement
license
Sites : [447] [448] [449] [450] [451] [452] [453] [454] [455] [456] [457] [458] [459] [460] [461] [462] [463] [464] [465] [466] next »